| Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling M Felcht, R Luck, A Schering, P Seidel, K Srivastava, J Hu, A Bartol, ... The Journal of clinical investigation 122 (6), 1991-2005, 2012 | 497 | 2012 |
| FOXC2 controls formation and maturation of lymphatic collecting vessels through cooperation with NFATc1 C Norrmén, KI Ivanov, J Cheng, N Zangger, M Delorenzi, M Jaquet, ... Journal of Cell Biology 185 (3), 439-457, 2009 | 366 | 2009 |
| Endothelial cell-derived angiopoietin-2 controls liver regeneration as a spatiotemporal rheostat J Hu, K Srivastava, M Wieland, A Runge, C Mogler, E Besemfelder, ... Science 343 (6169), 416-419, 2014 | 304 | 2014 |
| Pericyte-expressed Tie2 controls angiogenesis and vessel maturation M Teichert, L Milde, A Holm, L Stanicek, N Gengenbacher, S Savant, ... Nature communications 8 (1), 1-12, 2017 | 276 | 2017 |
| Angiopoietin 2 mediates microvascular and hemodynamic alterations in sepsis T Ziegler, J Horstkotte, C Schwab, V Pfetsch, K Weinmann, S Dietzel, ... The Journal of clinical investigation 123 (8), 3436-3445, 2013 | 204 | 2013 |
| Amelioration of sepsis by TIE2 activation–induced vascular protection S Han, SJ Lee, KE Kim, HS Lee, N Oh, I Park, E Ko, SJ Oh, YS Lee, D Kim, ... Science translational medicine 8 (335), 335ra55-335ra55, 2016 | 193 | 2016 |
| The orphan receptor Tie1 controls angiogenesis and vascular remodeling by differentially regulating Tie2 in tip and stalk cells S Savant, S La Porta, A Budnik, K Busch, J Hu, N Tisch, C Korn, AF Valls, ... Cell reports 12 (11), 1761-1773, 2015 | 151 | 2015 |
| Postsurgical adjuvant tumor therapy by combining anti-angiopoietin-2 and metronomic chemotherapy limits metastatic growth K Srivastava, J Hu, C Korn, S Savant, M Teichert, SS Kapel, M Jugold, ... Cancer cell 26 (6), 880-895, 2014 | 150 | 2014 |
| Endothelial cell-derived non-canonical Wnt ligands control vascular pruning in angiogenesis C Korn, B Scholz, J Hu, K Srivastava, J Wojtarowicz, T Arnsperger, ... Development 141 (8), 1757-1766, 2014 | 128 | 2014 |
| Semaphorin‐3C signals through Neuropilin‐1 and PlexinD1 receptors to inhibit pathological angiogenesis WJ Yang, J Hu, A Uemura, F Tetzlaff, HG Augustin, A Fischer EMBO molecular medicine 7 (10), 1267-1284, 2015 | 124 | 2015 |
| Feedback control of MKP-1 expression by p38 JH Hu, T Chen, ZH Zhuang, L Kong, MC Yu, Y Liu, JW Zang, BX Ge Cellular signalling 19 (2), 393-400, 2007 | 113 | 2007 |
| An essential function for β-arrestin 2 in the inhibitory signaling of natural killer cells MC Yu, LL Su, L Zou, Y Liu, N Wu, L Kong, ZH Zhuang, L Sun, HP Liu, ... Nature immunology 9 (8), 898-907, 2008 | 106 | 2008 |
| An essential role for RIG-I in toll-like receptor-stimulated phagocytosis L Kong, L Sun, H Zhang, Q Liu, Y Liu, L Qin, G Shi, JH Hu, A Xu, YP Sun, ... Cell host & microbe 6 (2), 150-161, 2009 | 97 | 2009 |
| Single‐cell transcriptomic analysis reveals a hepatic stellate cell–activation roadmap and myofibroblast origin during liver fibrosis in mice WU Yang, H He, T Wang, N Su, F Zhang, K Jiang, J Zhu, C Zhang, K Niu, ... Hepatology 74 (5), 2774-2790, 2021 | 85 | 2021 |
| Drosophila TAB2 is required for the immune activation of JNK and NF-kappaB ZH Zhuang, L Sun, L Kong, JH Hu, MC Yu, P Reinach, JW Zang, BX Ge Cellular signalling 18 (7), 964-970, 2006 | 75 | 2006 |
| Hepatic stellate cell‐expressed endosialin balances fibrogenesis and hepatocyte proliferation during liver damage C Mogler, M Wieland, C König, J Hu, A Runge, C Korn, E Besemfelder, ... EMBO molecular medicine 7 (3), 332-338, 2015 | 74 | 2015 |
| Development of potent and selective inhibitors targeting the papain-like protease of SARS-CoV-2 H Shan, J Liu, J Shen, J Dai, G Xu, K Lu, C Han, Y Wang, X Xu, Y Tong, ... Cell chemical biology 28 (6), 855-865. e9, 2021 | 73 | 2021 |
| Arid1a regulates response to anti-angiogenic therapy in advanced hepatocellular carcinoma C Hu, W Li, F Tian, K Jiang, X Liu, J Cen, Q He, Z Qiu, Y Kienast, Z Wang, ... Journal of hepatology 68 (3), 465-475, 2018 | 59 | 2018 |
| Junb regulates arterial contraction capacity, cellular contractility, and motility via its target Myl9 in mice AH Licht, T Nübel, A Feldner, N Jurisch-Yaksi, M Marcello, E Demicheva, ... The Journal of clinical investigation 120 (7), 2307-2318, 2010 | 54 | 2010 |
| Hepatocyte-specific TAK1 deficiency drives RIPK1 kinase-dependent inflammation to promote liver fibrosis and hepatocellular carcinoma S Tan, J Zhao, Z Sun, S Cao, K Niu, Y Zhong, H Wang, L Shi, H Pan, J Hu, ... Proceedings of the National Academy of Sciences 117 (25), 14231-14242, 2020 | 50 | 2020 |
